PUBLISHER: Grand View Research | PRODUCT CODE: 2040854
PUBLISHER: Grand View Research | PRODUCT CODE: 2040854
The global excipients market size was estimated at USD 10,690.68 million in 2025 and is projected to reach USD 14,746.68 million by 2033, growing at a CAGR of 4.11% from 2026 to 2033. Excipients are increasingly valued for enhancing drug functionality and offering a competitive edge in formulations, driving their widespread adoption among pharmaceutical companies.
Continuous research and development of optimized excipients for improved drug delivery have strengthened market growth, while the trend toward more advanced, multifunctional excipients is shaping the current pharmaceutical landscape. Excipients continue to play a critical role in enhancing drug functionality and improving patient outcomes, driving widespread adoption among pharmaceutical companies. Rising demand for advanced excipients that support nanoparticle drug delivery and targeted therapies in oncology, metabolic, and chronic disease treatments is boosting innovation and adoption. Patent expirations of major drugs are also encouraging the development of optimized formulations with multifunctional excipients to improve stability, solubility, and bioavailability.
Pharmaceutical firms are now actively engaged in R&D for next-generation excipients, focusing on compatibility with biologics, sustained-release formulations, and patient-friendly delivery systems. For instance, in December 2025, Pfizer Inc. and Cipla Ltd. entered a strategic partnership in India under which Cipla will exclusively market and distribute four key Pfizer brands across the country, combining Pfizer's established products with Cipla's extensive distribution network to expand access to essential medications nationwide, highlighting the role of collaborations in advancing drug formulation and delivery innovation.
The growing emphasis on customized drug delivery is further driving excipient innovation, as companies aim to improve bioavailability and patient compliance. Firms like Novartis AG, Sanofi S.A., and Teva Pharmaceutical Industries Ltd. are exploring multifunctional excipients for oral, injectable, and sustained-release formulations. Increasing collaborations between pharmaceutical and specialty chemical companies are accelerating the development of stable, high-performance excipients suitable for complex therapies. In addition, the integration of excipients in nanoparticle and biologic formulations is expanding their role in targeted treatment strategies. Regulatory agencies are also encouraging the adoption of advanced excipients through updated guidelines, ensuring safety and quality. Together, these trends are expected to sustain robust growth and innovation in the excipients sector over the coming years.
Global Excipients Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global excipients market report based on product, formulation, function, and region: